Wouldnt worry about it.This is Anagenics on the ASB platform and...

  1. 3,152 Posts.
    lightbulb Created with Sketch. 335
    Wouldnt worry about it.
    This is Anagenics on the ASB platform and needs updating as well.

    Cellmid Limited (CDY) is an Australian life sciences accelerator for indication of multiple diseases. It operates mainly through its wholly owned subsidiaries, Advangen Limited, Kinera and Lyramid Limited, that develop and market innovative novel therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company holds global intellectual properties relating to novel targets midkine and FGF5.

    SectorHousehold & Personal Products
    1Registered officeSuite 204, Level 2, , 55 Clarence St, , Sydney, NSW, Australia, 2000
    2Postal address
    3Telephone+61 2 9221 6830
    4Websitewww.cellmid.com.au
    5First listed09/12/2005
    6Balance date
    7AGM30/11/2020
    8Directors:
    9Chairman
    10Managing directorMatthew Dudek
    11Company secretaryMr Lee Tamplin
    12AuditorsPitcher Partners
    13Bankersn/a
    14Registry:Automic Registry Services, Level 5, , 126 Phillip St, Sydney, NSW, Australia, 2000, GPO Box 5193, Sydney,NSW,2001
    15Telephone+61 2 9698 5414
    16Facsimile+61 2 8583 3040
    17Websitewww.automicgroup.com.au
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $2.481M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 2276000 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 332362 2
View Market Depth
Last trade - 16.30pm 28/07/2025 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.